ZAI LAB LIMITED Operating Cash Flow
ZAI LAB LIMITED (ZLAB) reported Operating Cash Flow of -$75.32 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- ZAI LAB LIMITED net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$63.41M.
- ZAI LAB LIMITED net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$11.91M.
- ZAI LAB LIMITED net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$26.02M.
- ZAI LAB LIMITED net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$32.04M.
- ZAI LAB LIMITED net cash provided by (used in) operating activities for fiscal 2025 was -$150.79M.
- ZAI LAB LIMITED net cash provided by (used in) operating activities for fiscal 2024 was -$214.87M.
- ZAI LAB LIMITED net cash provided by (used in) operating activities for fiscal 2023 was -$198.18M.
- ZAI LAB LIMITED net cash provided by (used in) operating activities for fiscal 2022 was -$367.64M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$63.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$75.32M 10-Q · filed 2026-08-06 | -$101.34M derived: sum of 3 quarters · filed 2026-08-06 | -$133.38M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | -$11.91M 10-Q · filed 2026-05-07 | -$37.93M derived: sum of 2 quarters · filed 2026-05-07 | -$69.98M derived: sum of 3 quarters · filed 2026-05-07 | -$101.00M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | -$26.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$58.07M derived: sum of 2 quarters · filed 2026-02-26 | -$89.09M derived: sum of 3 quarters · filed 2026-08-06 | -$150.79M 10-K · filed 2026-02-26 | |
| 2025-09-30 | -$32.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$63.07M derived: sum of 2 quarters · filed 2026-08-06 | -$124.77M 10-Q · filed 2025-11-06 | -$180.54M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | -$31.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$92.72M 10-Q · filed 2026-08-06 | -$148.49M derived: sum of 3 quarters · filed 2026-08-06 | -$175.31M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | -$61.70M 10-Q · filed 2026-05-07 | -$117.47M derived: sum of 2 quarters · filed 2026-05-07 | -$144.29M derived: sum of 3 quarters · filed 2026-05-07 | -$186.46M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | -$55.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$82.59M derived: sum of 2 quarters · filed 2026-02-26 | -$124.76M derived: sum of 3 quarters · filed 2026-02-26 | -$214.87M 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$26.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$68.99M derived: sum of 2 quarters · filed 2025-11-06 | -$159.10M 10-Q · filed 2025-11-06 | -$174.02M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | -$42.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$132.28M 10-Q · filed 2025-08-07 | -$147.20M derived: sum of 3 quarters · filed 2026-02-26 | -$202.47M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | -$90.11M 10-Q · filed 2025-05-08 | -$105.02M derived: sum of 2 quarters · filed 2026-02-26 | -$160.29M derived: sum of 3 quarters · filed 2026-02-26 | -$219.00M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | -$14.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$70.19M derived: sum of 2 quarters · filed 2026-02-26 | -$128.89M derived: sum of 3 quarters · filed 2026-02-26 | -$198.18M 10-K · filed 2026-02-26 | |
| 2023-09-30 | -$55.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$113.97M derived: sum of 2 quarters · filed 2024-11-12 | -$183.26M 10-Q · filed 2024-11-12 | -$292.55M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | -$58.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$127.99M 10-Q · filed 2024-08-06 | -$237.28M derived: sum of 3 quarters · filed 2025-02-27 | -$363.60M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | -$69.29M 10-Q · filed 2024-05-08 | -$178.58M derived: sum of 2 quarters · filed 2025-02-27 | -$304.90M derived: sum of 3 quarters · filed 2025-02-27 | -$349.80M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | -$109.29M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$235.62M derived: sum of 2 quarters · filed 2025-02-27 | -$280.51M derived: sum of 3 quarters · filed 2025-02-27 | -$367.64M 10-K · filed 2025-02-27 | |
| 2022-09-30 | -$126.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$171.22M derived: sum of 2 quarters · filed 2023-11-07 | -$258.35M 10-Q · filed 2023-11-07 | -$411.34M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-06-30 | -$44.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$132.03M 10-Q · filed 2023-08-07 | -$285.02M derived: sum of 3 quarters · filed 2024-02-27 | -$445.91M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-03-31 | -$87.13M 10-Q · filed 2023-05-09 | -$240.12M derived: sum of 2 quarters · filed 2024-02-27 | -$401.01M derived: sum of 3 quarters · filed 2024-02-27 | -$466.86M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2021-12-31 | -$152.99M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$313.88M derived: sum of 2 quarters · filed 2024-02-27 | -$379.73M derived: sum of 3 quarters · filed 2024-02-27 | -$549.23M 10-K · filed 2024-02-27 | |
| 2021-09-30 | -$160.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$226.74M derived: sum of 2 quarters · filed 2022-11-09 | -$396.24M 10-Q · filed 2022-11-09 | -$440.57M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | -$65.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$235.35M 10-Q · filed 2022-08-09 | -$279.68M derived: sum of 3 quarters · filed 2023-03-01 | -$359.08M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-03-31 | -$169.50M 10-Q · filed 2022-05-10 | -$213.84M derived: sum of 2 quarters · filed 2023-03-01 | -$293.24M derived: sum of 3 quarters · filed 2023-03-01 | -$345.71M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2020-12-31 | -$44.34M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$123.74M derived: sum of 2 quarters · filed 2023-03-01 | -$176.21M derived: sum of 3 quarters · filed 2023-03-01 | -$216.06M 10-K · filed 2023-03-01 | |
| 2020-09-30 | -$79.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$131.88M derived: sum of 2 quarters · filed 2021-11-09 | -$171.72M 10-Q · filed 2021-11-09 | -$211.74M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | -$52.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$92.32M 10-Q · filed 2021-08-09 | -$132.34M derived: sum of 3 quarters · filed 2022-03-01 | -$200.15M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | -$39.84M 10-Q · filed 2021-05-10 | -$79.86M derived: sum of 2 quarters · filed 2022-03-01 | -$147.67M derived: sum of 3 quarters · filed 2022-03-01 | ||
| 2019-12-31 | -$40.02M derived: 10-K 12 month − 6-K 9 month · filed 2022-03-01 | -$107.83M derived: sum of 2 quarters · filed 2022-03-01 | -$191.01M 10-K · filed 2022-03-01 | ||
| 2019-09-30 | -$67.81M derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | -$150.99M 6-K · filed 2020-01-21 | |||
| 2019-06-30 | -$83.18M 6-K · filed 2020-09-11 | ||||
| 2018-12-31 | -$44.63M derived: 10-K 12 month − 6-K 9 month · filed 2021-03-01 | -$97.54M 10-K · filed 2021-03-01 | -$97.54M 20-F · filed 2019-03-29 | ||
| 2018-09-30 | -$52.91M 6-K · filed 2020-01-21 | ||||
| 2017-12-31 | -$32.37M 20-F · filed 2020-04-29 | -$32.37M 20-F · filed 2019-03-29 | |||
| 2016-12-31 | -$32.16M 20-F · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |